Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt–Jakob disease
暂无分享,去创建一个
Y. Shiga | K. Satoh | M. Tobiume | N. Nishida | S. Shirabe | Y. Matsui | T. Sata | K. Mutsukura | Katsumi Eguhchi | Susumu Shirabe
[1] H. Kretzschmar,et al. 14-3-3 CSF levels in sporadic Creutzfeldt–Jakob disease differ across molecular subtypes , 2009, Neurobiology of Aging.
[2] K. Eguchi,et al. Total Tau Protein in Cerebrospinal Fluid and Diffusion-Weighted MRI as an Early Diagnostic Marker for Creutzfeldt-Jakob Disease , 2007, Dementia and Geriatric Cognitive Disorders.
[3] K. Eguchi,et al. Chronological Changes in MRI and CSF Biochemical Markers in Creutzfeldt-Jakob Disease Patients , 2007, Dementia and Geriatric Cognitive Disorders.
[4] K. Hess,et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.
[5] Y. Itoyama,et al. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages , 2006, Journal of clinical neuroscience.
[6] Tomoyuki N. Tanaka,et al. Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases. , 2003, The Journal of general virology.
[7] J. Martín,et al. A prospective study of CSF markers in 250 patients with possible Creutzfeldt–Jakob disease , 2003, Journal of neurology, neurosurgery, and psychiatry.
[8] D. Lanska. Diagnosis of Creutzfeldt–Jakob disease: Effect of clinical criteria on incidence estimates Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2001, Neurology.
[9] P Brown,et al. Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.